Confirmation that inhibitors of p38 MAPK and NF-kB inhibit their respective pathways Treatment of hippocampal astrocytes with (A) IL-1b or (B) TNF-a in the absence or presence of the p38 MAPK inhibitor showed that SB203580 inhibited p38 MAPK phosphorylation induced by either ligand. (C) To confirm the inhibitory effect of SN-50 on NF-kB nuclear translocation, astrocytes were pretreated with vehicle or with 10 mM SN-50 for 30 min and then treated with IL-1b or TNFa for 30 min. Cells were fixed and stained for p65, and nuclei were labelled with Hoechst stain. Nuclear staining of p65 was observed in IL-1b-or TNF-a-treated astrocytes without SN-50 (indicated by arrows; note the pink colour of the nuclei), and nuclear translocation of p65 was blocked by SN-50 (bottom panels).
Figure S1
Confirmation that inhibitors of p38 MAPK and NF-kB inhibit their respective pathways Treatment of hippocampal astrocytes with (A) IL-1b or (B) TNF-a in the absence or presence of the p38 MAPK inhibitor showed that SB203580 inhibited p38 MAPK phosphorylation induced by either ligand. (C) To confirm the inhibitory effect of SN-50 on NF-kB nuclear translocation, astrocytes were pretreated with vehicle or with 10 mM SN-50 for 30 min and then treated with IL-1b or TNFa for 30 min. Cells were fixed and stained for p65, and nuclei were labelled with Hoechst stain. Nuclear staining of p65 was observed in IL-1b-or TNF-a-treated astrocytes without SN-50 (indicated by arrows; note the pink colour of the nuclei), and nuclear translocation of p65 was blocked by SN-50 (bottom panels). Figure S2 Hippocampal neurons were treated with or without biotin Cells were processed as indicated in Figure 6 of the main paper, lysates were precipitated with streptavidin and analysed by Western blot for p75 NTR levels. In the absence of biotin, no p75 NTR was detected.
